Holly Blankenship, DO
Adult Medicine · Woodbury, TNNPI 1386878957
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $305 and has fallen 95.3% since, to $14 in 2021. That places this record below the midpoint for adult medicine clinicians in TN, where the typical reported total is $686.
Across 27 payments — averaging $13.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$68
- Novo Nordisk$53
- Pfizer$48
- Lilly USA, LLC$44
- Takeda Pharmaceuticals U.S.A., Inc.$39
- Sanofi-aventis U.S. LLC$35
- plus $86 from 5 others
What the payments were for
- Food & beverage$375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $68 |
| Novo Nordisk | 4 | $53 |
| Pfizer | 4 | $48 |
| Lilly USA, LLC | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $39 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Shire North American Group Inc | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $14 |
| AbbVie | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$375 in reported general payments places this provider in the 40th percentile of 22 adult medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 18 | $7,071 |
| PrilosecOmeprazole Magnesium | 11 | $5,164 |
| Potassium Chloride | 13 | $238 |
| Omeprazole | 20 | $192 |
| Simvastatin | 22 | $184 |
| Levothyroxine Sodium | 20 | $173 |
| Famotidine | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Woodbury
- Michael KelloggGallatin$19K
- Paul BoeremaCleveland$11K
- Dennis ThompsonCleveland$10K
- William HaysCleveland$10K
- Cynthia ShafferOoltewah$5K
- Allan ChastainCleveland$4K
- John LeeMurfreesboro$4K
- Bojidar DolaptchievNewport$2K
- John SherrillBristol$1K
- Jung ParkDunlap$889
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.